Tranzyme, Inc. (TZYM) Reports In-Line Q2 Loss of 23c/Share
Get Alerts TZYM Hot Sheet
Join SI Premium – FREE
Tranzyme, Inc. (NASDAQ: TZYM) reported Q2 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $2.41 million versus the consensus estimate of $2.97 million.
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- South Plains Financial Inc. (SPFI) Tops Q1 EPS by 6c
- Primis Financial (FRST) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!